Keywords: pramipexole, reduces, sleep, disturbance, rls, new, study
Pramipexole reduces sleep disturbance in RLS
Article | 28 April 2008
New study data show that German drug major Boehringer Ingelheim's pramipexole (Mirapexin/Sifrol) can significantly reduce sleep disturbance, often the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
